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Objective: To compare the basic proteomic composition of abdominal aortic aneurysm (AAA) wall tissue in patients with
nonruptured and ruptured aneurysms.
Methods: A proteomic approach with two-dimensional gel electrophoresis (2D-PAGE) and mass spectrometry (MS) was
used to identify differentially expressed proteins in AAA tissue from nine patients with nonruptured and eight patients
with ruptured AAA. Computerized image analysis was used to detect protein spots. Differentially expressed protein spots
were in-gel digested and identified by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Western blot
analysis was used to confirm differential expression.
Results: Seven differentially expressed proteins were detected among 745 protein spots, selecting spots whose average
relative volumes differed more than twofold between the nonruptured and the ruptured group. Four protein spots were
up-regulated in the ruptured group, and three were down-regulated. Five of the spots were identified. Among the
upregulated spots, No. 605 was identified as peroxiredoxin-2. The up-regulation was confirmed by Western blotting. No.
381 was identified as an actin fragment. Two spots, Nos. 719 and 499, could not be identified. Among the
down-regulated protein spots, No. 130 contained two peptides; one reliably determined peptide, FEDGVLDPDYPR, is
found in vitronectin. Another peptide, QIDNPDYK, was borderline significant and found in calreticulin. The down-
regulation of vitronectin was confirmed by Western blotting. Spot Nos. 193 and 199 both contained peptides from
albumin with actin also present in No. 199.
Conclusion: The identified proteins suggest that the aortic wall of ruptured aneurysms responds to a stressful condition
and that proteolytic degradation of the cytoskeleton and connective tissue may be part of the response. ( J Vasc Surg
2009;49:455-63.)
Clinical Relevance: The use of biomarkers in medicine lies in their ability to detect disease and to support diagnostic and
therapeutic decisions. Proteins are the main functional outcomes of genes, so proteomics will lead biology and medicine
beyond genomics. The identification, quantification, classification, and functional assignment of proteins will be
essential to the full understanding of the molecular events of AAA progression. New research and novel understand-
ing of the molecular basis of the disease reveal an abundance of exciting new biomarkers that present a promise for
use in the everyday clinical practice. Consequently, the blood level of an ideal biomarker should have: high sensitivity
(increased pathologically in the presence of the disease), high specificity (not increased in the absence of the disease),
add information about the risk or prognosis, change in accordance with the clinical evolution, reflecting the current
status of disease, be reproducible (as determined by the low coefficient of variation), and be easy and less expensive
to determine. The identification of such biomarkers also causes identification of potential pathogenetic pathways,
and may thus open possibilities for pharmacological inhibition of growth and provide a tool for monitoring this
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Vascular Surgery.doi:10.1016/j.jvs.2008.08.097Ruptured abdominal aortic aneurysm (AAA) is a serious
clinical problem that requires an emergency repair associ-
ated with a high mortality rate.1 Growth and rupture of
AAA is characterized by inflammation of the arterial wall,
increased expression of matrix-degrading metalloprotein-
ases (MMPs) and their inhibitors, degenerative changes in
elastin, and collagen and apoptosis of the smooth muscle
cells of the media.2 An effort to prevent rupture by early
detection of AAA may reduce very high mortality rates
associated with rupture by providing the opportunity for
elective repair. Regrettably, it is often difficult to predict an
adverse outcome.
Proteolytic degradation of the elastin and collagen
fibers as well as different proteases and their inhibitors have
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the processes that characterize AAA rupture are poorly
understood. If reliable predictors of rupture can be deter-
mined, they hold the potential to provide for the indication
of surgery and may reveal modifiable risk factors for AAA
progression and rupture.
In recent years, genomics has increased the understand-
ing of many diseases. Although genetic mutations and/or
altered gene expression may underlie a disease, the bio-
chemical basis for diseases is caused by distortions in the
proteins. We have used a combination of two-dimensional
polyacrylamide gel electrophoresis (2D-PAGE) for protein
separation and visualisation followed by mass spectrometry
(MS) protein identification.6 We report the differential
expression of seven proteins in the ruptured group vs the
nonruptured group. The differential expression of the pro-
teins in the disease is discussed in relation to the functions
of the proteins.7
MATERIALS AND METHODS
Patients and tissue sampling
AAA wall samples were used from 17 patients who
underwent infrarenal AAA repair between 1998 and 2000
at the Department of Vascular Surgery, Viborg Hospital.
Eight had ruptured AAA.
Full AAA thickness tissue were collected from the an-
terior wall of the aneurysm at the maximal dilated place,
cleaned from blood, fat, and foreign tissues. Areas of defi-
nite, hard calcification were discarded. When tissue was
taken from the patient, in a few days it was frozen at
20°C. For longer term storage, the tissue was transferred
to a 80°C freezer. The maximal anterior-posterior di-
ameter of AAA was measured by computed tomography
(CT) scanning within a month before surgery. In ruptured
cases, this was done immediately before surgery.
All patients, or close relatives as deputies in cases of
incapacity of the patient, were informed and gave consent
to this procedure. This study was approved by the Scientific
Ethical Committee and reported to the data protection
authorities.
Two-dimensional gel electrophoresis
Approximately 1 g of complete AAA wall tissue was
frozen in liquid nitrogen, crushed with a hammer between
plastic sheets, dissolved in lysis buffer (pH 3-10 NL),
homogenized with an Ultra-Turax homogenizer and cen-
trifuged at 14,000 rpm for 10 minutes. Rehydration buffer
was added to the supernatant and first dimension was run
on pre-cast immobilized pH gradient strips (18 cm; pH
3-10 NL) with the Multiphor II system (GE Healthcare,
Chalfont St. Giles, UK). The second dimension was per-
formed on home made polyacrylamide gels (12% T, 3% C)
that were fixed in 50% (v/v) methanol, 12% (v/v) acetic
acid, or 0.0185% (v/v) formaldehyde for at least 1 hour or
overnight. They were then washed three times for 20
minutes in 35% (v/v) ethanol, pretreated for 1 minute in
pretreatment solution (0.02% (w/v) Na2S2O3, 5H2O) andrinsed two times for 3minutes in water. Staining of gels was
performed for 20 minutes in 0.2% (w/v) AgNO3, 0.028%
(v/v) formaldehyde after which they were rinsed two times
for 20 seconds in water. Development was carried out in
development solution (6% [w/v] Na2CO3, 0.0185% [v/v]
formaldehyde, 0.0004% [w/v] Na2S2O3, and 5H2O) for
approximately 3 minutes and was stopped in stop solution
(50% [v/v] methanol, 12% [v/v] acetic acid). Finally, the
gels were dried between cellophane sheets and sealed in
plastic bags.
Analysis of two-dimensional gels
Analysis of gels was performed essentially as previously
described.8 In short, the dry and transparent silver stained
gels were scanned in the transmissive mode on a GS-710
imaging densitometer from Bio-Rad (Hercules, Calif) us-
ing the Quantity One software package. Gel images were
exported as 16-bit gray-scale TIFF files that were imported
into the Melanie II (Swiss Institute of Bioinformatics,
Geneva, Switzerland) 2-D PAGE analysis software package.
After background subtraction, the protein spots were auto-
matically defined and quantified with the feature detection
algorithm as described in the manual. Spot intensities were
expressed as relative volumes in percentages (%VOL) by
integrating the optical density of each pixel in the spot area
(VOL) and dividing with the sum of volumes of all spots
detected in the gel. About 10 to 12 of the spots were used
as landmarks. One of the gels used in an analysis compari-
son was selected as a reference gel to which each other gel
used in the analysis was aligned andmatched to as described
in the manual. In the reference gel, each spot (feature) is
assigned with a number. The quality of the match made by
the computer was critically evaluated in each case and
necessary editions and corrections were done manually.
Comparison of groups
Comparisons were performed between two groups of
gels (group A-nonruptured AAA and group B-ruptured
AAA) first by selecting spots with an average relative vol-
ume in one group differing by more than twofold with the
average relative volume in the other group. Significant
differences among the selected spots were calculated using
a two-sample t test (P .05). These data were exported to
Excel for further analysis. Only data that could be consid-
ered as normal distributed as checked by a Shapiro-Wilcox
analysis were used. Comparisons were made between pairs
of groups with eight to nine gels in each group. Only well
focused spots were considered.
Identification of proteins by liquid chromatography-
tandem mass spectrometry (LC-MS/MS)
Gels containing protein spots selected for identification
were re-swelled in water. The cellophane sheets were
peeled off so the protein spots could be excised from the
gels. Proteins were subjected to in-gel tryptic digestion and
identification, essentially as previously described.8 In short,
the digested sample was dried and the peptides resus-
pended in 12 l buffer A (water/acetonitrile/formic acid,
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inert nano LC system composed of a FAMOS micro auto
sampler, a Switchos micro column switching module, and
an Ultimate micro pump from LC Packings (San Francisco,
Calif). After preconcentration of 5 l of the sample on the
precolumn the peptides were eluted from the analytical
column with a gradient made by mixing decreasing vol-
umes of buffer A with increasing volumes of buffer B
(water/acetonitrile/formic acid, 9.7/90/0.3, V/V/V).
The peptides were eluted into the nano electrospray ion
source of the quadruple time-of-flight Q-TOFUltimamass
spectrometer (Micromass, Manchester, UK). MS survey
scans were acquired using MassLynx 4 SP4 (Waters, Mil-
ford,Mass) at a rate of 1 per second fromm/z 400 to 2000.
The instrument was operated in a data-dependent MS to
MS/MS switching mode where doubly, triply and quadru-
ply charged peptide ions detected in MS survey scans
triggered a switch to MS/MS for obtaining peptide frag-
mentation spectra with an interval of m/z values 50 to
2000. The obtained raw data were processed using Protein-
Lynx GlobalServer 2.1 (Waters, Milford, Mass). The pro-
cessed data were used to search the SwissProt database with
the on-line version of the Mascot MS/MS ion search
facility (Matrix Science, Ltd., London, UK, http://ww-
w.matrixscience.com).9 Searching was performed with
doubly and triply charged ions with two missed cleavages; a
peptide tolerance of 50 ppm, one modification, Carbam-
idomethyl-C and an MS/MS tolerance of 0.05 Da. Con-
taminating proteins including keratins, trypsin, and bovine
serum albumin were disregarded. At least one “bold red”
peptide was required in the search. The peptides are re-
ported for proteins with scores giving a less than 5% prob-
ability that the observed match was a random event.
Western blotting
For one-dimensional Western blotting protein concen-
trations of samples were determined using a noninterfering
assay (NI Protein Assay, Geno Technology Inc., St Louis,
Mo). Identical amounts of protein from each sample (5 or
10 g total protein) were added to each lane of a 10% to
20% and 4% to 20% Tris-Glycine gel (Invitrogen, Carlsbad,
Calif). After electrophoresis, the proteins were transferred
to nitrocellulose membranes. For immunodetection of the
proteins the nitrocellulose sheets were incubated overnight
Table I. Patient characteristics
Nonruptur
n  9
Gender: males/females 6/3
Age (y) Median (range) 71.6 (68-7
Aneurysm diameter (mm) Median (range) 56.2 (35-8
Smoking status (smokers/nonsmokers) 5/4
NSAID (Y/N) 4/5
Statins (Y/N) 0/9
Outcome (A/D) 9/0at 4°C in phosphate-buffered saline (PBS) (2.7 mM KCl,1.8 mM KH2PO4, 10.1 mM Na2HPO4, 140 mM NaCl,
pH 7.3) containing 0.05% Tween-20 and 5% skimmed
milk. The membranes were washed five times in PBS with
0.05% Tween-20. Rabbit polyclonal antibody to peroxire-
doxin-2 (Abcam, Cambridge, UK) was diluted to 1:2000,
rabbit polyclonal antibody to vitronectin sc-28929 (Santa
Cruz Biotechnology, Inc, Santa Cruz, Calif) was diluted
1:1000, and rabbit polyclonal antibody to calreticulin (Ab-
cam, Cambridge, UK) was diluted 1:1000. The blots were
incubated with antibodies for 1 hour at room temperature.
After five washes in PBS with Tween-20, the blots were
incubated for another hour with 1:1000 diluted peroxi-
dase-conjugated swine antirabbit IgG (Dako, Glostrup,
Denmark). Finally, the membranes were washed five times
in PBS with Tween-20 and developed with the enhanced
chemiluminescence technique (Amersham Biosciences
Inc.). Blots were quantified using Imaging Densitometer
GS710 andQuantityOne software (Bio-Rad, Switzerland).
RESULTS
There were 11 male and 6 female patients. The mean
age was 73.5  6.8 years and the age range was 66 to 83
years. The characteristics of the patients are given in Table I.
There is no significant difference between the groups of
nonruptured vs ruptured with respect to gender, age, an-
eurysm diameter, smoking status, or ingestion of nonste-
roidal anti-inflammatory drugs.
Comparison of protein expression profiles
Fig 1 shows representative gels of aortic tissue from
nonruptured aneurysms (A) and aortic tissue from acute
ruptured aneurysms (B). In all analyses, the nonruptured
aortic tissue was used as reference. About 745 paired pro-
tein spots were visualized. Seven protein spots were found
to be more than twofold differentially expressed at the
significance level of P  .05. Four proteins were up-
regulated and three were down-regulated (Fig 2). They are
all indicated with arrows in Fig 1.
Protein identification
All seven proteins were excised from the rehydrated
gels and subjected to in-gel tryptic digestion for subsequent
identification by LC-MS/MS. Among seven spots that
were excised for identification, five of the spots contained
Ruptured Total
Pn  8 n  17
5/3 11/6 NS
75.4 (68-83) 73.5 (68-83) NS
57 (49-90) 56.6 (35-90) NS
4/4 9/8 NS
2/6 6/11 0.62
0/8 0/17 0.99
5/3 14/3 0.08ed
5)
0)peptides for putative identification, two up-regulated spots
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tides that were obtained and used to identify the proteins
and the degree of differential expression. Examples of the
spectral data that were used to identify the proteins are
given in Figs 3 and 4.
Spot 719. Spot 719 was 19.5-fold up-regulated in the
ruptured group. Although several spots were excised for
identification, we obtained no certain identification proba-
bly because of very low amounts present in the spot.
Spot 605. Spot 605 was up-regulated 8.1-fold in the
ruptured group as determined by 2D-PAGE. The spectral
data used for the identification is shown in Fig 3. The three
peptides are present in peroxiredoxin-2 with a score at 125
well above the significance limit indicating that the identi-
fication was very reliable. The Western blot analysis of
peroxiredoxin-2 (Fig 5) revealed expression of an approxi-
mately 20 kDa protein band, which confirmed the 2D-
PAGE analysis. Western blot analysis indicated that the
peroxiredoxin-2 level was significantly 2.2-fold up-
regulated in aortic tissue from ruptured aneurysms com-
pared with aortic tissue from nonruptured aneurysms, op-
Fig 1. Two-dimensional gel images of non-ruptured abdominal
aortic aneurysms (A) and ruptured abdominal aortic aneurysms
(B). Proteins that were significantly differentially expressed more
than two-fold are indicated with arrows (upward pointing, up-
regulated; downward pointing, down-regulated). Five of the pro-
teins were identified using LC-MS/MS as indicated in Table I
where also the degree of up- and down-regulation is given.erated electively (Fig 5).Spot 499. Spot 499 was up-regulated in the ruptured
group by 4.9-fold. The spot was not identified, although
excised several times, probably due to low amounts of
protein present.
Spot 381. Spot 381 was identified as a fragment of
either beta or gamma actin. The fragment was 2.7-fold
up-regulated in the ruptured group.
Spot 130. Spot 130 was 5.4-fold down-regulated in
ruptured AAA walls. The database search revealed two
peptides that fitted the spectral data as shown in Fig 4. One
peptide, FEDGVLDPDYPR, quite reliably fitted (score
54) the spectrum as seen in Fig 4, A. This peptide is found
in the multifunctional glycoprotein vitronectin and is also
present in the 40-kDa aortic aneurysm associated protein-40
(AAAP-40) that possesses similarity to vitronectin, fibrino-
gen as well as several calcium binding proteins. The latter
protein AAAP-40, however, possesses a lower molecular
mass 40 kDa than observed from the 2D gels, ie, around 50
kDa. Another peptide, QIDNPDYK, also fitted the spectral
data (score 36) shown in Fig 4, B. However, the score
obtained in the search was only 36, which is just borderline
significant as seen in Table II. Thus, this identification is
less reliable than in case of vitronectin. An additional search
using another search program (Gobal server) also scores
vitronectin (score 12.5; probability 100%) significantly
higher than calreticulin (score 10.4; probability 12.49%).
Moreover, Western blot analysis of vitronectin expression
Fig 2. Protein levels as spot volume percentages of seven signifi-
cantly and more than two-fold differentially expressed proteins
from non-ruptured (X) and ruptured (●) abdominal aneurysms.
The mean values in each group are indicated and connected.revealed the presence of mainly two protein bands with
tly hig
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kDa band corresponds to spot 130 as detected by 2D-
PAGE (Fig 1). The two bands were quantitated together
revealing a 2.9-fold significant down-regulation of vitro-
nectin in aortic tissue from ruptured aneurysms (Fig 5).
Western blot of calreticulin was unreliable, since it gave
several weak bands indicating that the amount of the pro-
tein in the tissue was too low to give a clear and specific
reaction with the antibody used.
Spot 193. Spot 193 was identified as albumin being
twofold down-regulated in the ruptured AAA group.
Spot 199. Spot 199, which was twofold down-
regulated in the ruptured group, was identified with several
peptides as albumin. The spot also contained some actin
peptides where several isoforms are possible based on the
two peptides identified, aortic smooth muscle actin (ACTA_
HUMAN), beta actin (ACTB_HUMAN), gamma actin
(ACTG_HUMAN), cardiac alpha actin (ACTC_HUMAN),
enteric smoothmuscle gamma actin (ACTH_HUMAN), and
skeletal muscle alpha actin (ACTS_HUMAN).
DISCUSSION
Fourmechanisms seem to be relevant for the pathogen-
esis of aneurysm formation: proteolytic degradation of
aortic wall connective tissue, inflammation and immune
responses, biomechanical wall stress, and molecular genet-
Table II. Proteins that are differentially expressed in ruptu
aneurysms
Protein
No. Peptides analyzed MS identificatio
719 NIb
605 LSEDYGVLK (110-118) Peroxiredoxin-2
TDEGIAYR (119-126)
QITVNDLPVGR (139-149)
499 NIb
381 GYSFTTTAER (197-206) Actin, cytoplasmic 1 (
actin)
199 LVNEVTEFAK (66-75) Albumin
YLYEIAR (162-168)
YICENQDSISSK (287-298)
VPQVSTPTLVEVSR (439-452)
AGFAGDDAPR (20-29)
EITALAPSTMK (317-327)
Actin, gamma-enteric
muscle (smooth mu
gamma actin)
193 LVNEVTEFAK (66-75) Albumin
130 FEDGVLDPDYPR (230-241) Vitronectin
QIDNPDYK (279-286)c Calreticulin
aA Mascot score above 36 indicates a significant identity when searching in
bNot identified
cThe score for vitronectin is well above the significance level whereas calretic
performed with a different search program (Global server) giving a significan
score for calreticulin (score 10.4; probability 12.49%).ics.10 However, the specific pathogenetic mechanisms un-derlying the progression of nonruptured into ruptured
abdominal aneurysms are still largely unknown. In this
article, we present the first proteomic study comparing
nonruptured with ruptured abdominal aneurysms using
2D-PAGE and MS identification. We detected differen-
tially expressed proteins in tissue from ruptured aneurysms
compared with nonruptured AAA tissue. Among these, we
identified two up-regulated proteins and three down-
regulated in the wall of ruptured AAA and suggest an
association between these proteins and rupture of the an-
eurysm in the human abdominal aorta. Three of the iden-
tified proteins were also analysed by Western blot analysis.
Two of the antibodies gave reliable results and confirmed
the differential expression observed by 2D-PAGE.
Spot 605 identified as peroxiredoxin-2. In the
present study, peroxiredoxin-2 was up-regulated 8.1-fold
in the ruptured AAA group compared with nonruptured
AAA as determined by 2D-PAGE. Western blot analysis
confirmed the significant up-regulation of peroxiredoxin-2
in ruptured aortic tissue. Peroxiredoxins are a family of
antioxidative proteins that share a common reactive cys-
teine residue in the N-terminal region and eliminate hydro-
gen peroxide (H2O2).
11 Intracellular peroxiredoxins have
been implicated in cellular antioxidant defence and the
regulation of many cellular processes including cell prolif-
eration, differentiation, and apoptosis.12-14 Overexpression
abdominal aortic aneurysms vs nonruptured abdominal
Accession (SwissProt) (pI; Mr)
Mascot
scorea
Level in ruptured
group vs level in
nonruptured group
19.5
PRDX2_HUMAN (5.67;
21.747)
125 8.09
4.85
ACTB_HUMAN or
ACTG_HUMAN (5.29;
41.7-41.8)
53 2.67
ALBU_HUMAN 103 0.5
th ACTA_HUMAN,
ACTB_HUMAN,
ACTC_HUMAN,
ACTG_HUMAN,
ACTH_HUMAN or
ACTS_HUMAN (5.31;
41.7-41.8)
55
ALBU_HUMAN (6.25; 69.3) 60 0.5
VTNC_HUMAN (5.7; 54.3) 54c 0.18
CALR_HUMAN (4.3; 48.1) 36c
tal database (P  .05).
of borderline significance. This result was also obtained when searching was
her score for vitronectin (score 12.5; probability 100%) and an insignificantred
n
Beta-
smoo
scle
the to
ulin isof genes for peroxiredoxin-2 in human endothelial cells
ith b
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15 The
increase in peroxiredoxin-2 concentration may be second-
ary to specific mechanisms involved in the response to
injury associated with ruptured AAA. However, the role of
reactive oxygen species (ROS) and antioxidants in aneu-
rysm disease is an area of great interest as well. Among
ROS, the accession of superoxide anion (O2
) contributes
to the functional and structural changes of the vessel wall.
Superoxide (O2
) levels in aneurysmal tissue in human
beings is 2.5-fold higher than adjacent, nonaneurysmal
aortic tissue and 10-fold higher than control aorta.16 This
pro-oxidant environment has important implications for
matrix degradation and activates MMPs suggesting a pos-
Fig 3. Identification of spot No. 605 by LC-MS/MS. T
peroxiredoxin-2. The identified peptides are indicated wsible role of oxidative stress in the pathogenesis of abdom-inal aortic aneurysms.17,18 Previous experiments indicate
that ROS and oxidative stress are locally enhanced in AAA
and may play a pivotal role in the pathologic progression of
AAA.19,20 Collectively, these studies provide support for
the hypothesis that oxidative stress is an important compo-
nent in formation and enlargement of AAA through acti-
vation of MMPs and induction of apoptosis within the
aortic wall.
Spot 193 and 199 were identified as albumin.
Albumin was found to be twofold down-regulated in the
ruptured AAA group based on spot 193. This could be due
to a response to the rupture of the aneurysm. Vascular
inflammation and proteolytic degradation are implicated in
tandemmass spectra used to reliably identify spot 605 as
old in the sequence.hreethe pathogenesis of AAA. The down-regulation could re-
ance w
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the wall or as a result of an increased proteolytic degrada-
tion of albumin in the wall.
Spot 199 and 381 are identified as actin. Actin was
found in spot 199 together with albumin. In spot 381, an
actin fragment was found to be 2.7-fold up-regulated in
ruptured AAA. Actin exists ubiquitously as a structural
constituent of the cytoskeleton and plays a role in motor
activity. Up-regulation of an actin fragment may be due to
an increased proteolytic degradation of actin in the rup-
tured aneurysm.
Spot 130 is likely identified as vitronectin. Vitronectin
is likely to account for the major changes of spot 130.
Although spot 130 contained spectra from two different
proteins the major content, and thereby, the major change
in protein is likely to be vitronectin based on the quality of
the data used for identification. This interpretation was
further substantiated by Western blot analysis that also
revealed significant down-regulation of two vitronectin
bands in the ruptured abdominal aorta group. Vitronectin
is an adhesive multifunctional glycoprotein circulating in
the plasma, and in the extracellular matrix, including the
vascular wall, and play key roles in the migration, attach-
Fig 4. Identification of spot No. 130 by LC-MS/MS. F
Shows a high quality spectrum that is compatible with a p
peptide from spot No. 130 showed a borderline significment, and differentiation of cells.21-23 This protein also hasseveral other functions in the complement, coagulation,
and fibrinolytic system. Limited proteolysis by plasmin
converts vitronectin into defined fragments, which are
detectable at sites of inflammation and angiogenesis.24
Plasmin is important in the degradation of matrix glycop-
roteins such as fibronectin, vitronectin, and laminin, all of
which have been reported to bind plasminogen activator
inhibitor-1 (PAI-1). 25,26 Decreased PAI-1 activity leads to
increased activity of urokinase-like-plasminogen activator
(u-PA) and tissue-type-plasminogen activator (t-PA) to
promote cellular migration and matrix remodeling. The
data also suggest thatMMPs such asMMP-9,MMP-2, and
MMP-12 may be responsible for the pathological degrada-
tion and/or normal turnover of vitronectin.27,28 There-
fore, the degradation of the matrix, which occurs during
tissue remodelling involves both plasminogen activators
and activators of metalloproteases,29,30 and vitronectin
provides unique regulatory links between cell adhesion and
proteolytic enzyme cascades. In a rat model, blocking of
t-PA activity by PAI-1 overexpression prevents formation
of aneurysms and arterial rupture by inhibiting MMP acti-
vation.31
Taken together, the present results suggest that the
pot No. 130 two tandemmass spectra were obtained.A,
e found in vitronectin (shown with bold). B, A different
ith a peptide in calreticulin (shown with bold).rom s
eptidincreased concentration of peroxiredoxin-2, the putative
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in the wall of ruptured AAA patients as well as the up-
regulation of an actin fragment may be related to a change
in proteolytic activity and inflammatory response linked
with AAA progression and rupture. AAA size is also a
strong predictor of AAA rupture. In our material, there was
no significant difference in size between the groups being
averagely 56.2 mm in the nonruptured group and 57 mm
in the ruptured group (Table I). In order to standardize
the material, each sample was taken at the anterior wall of
the AAA at the maximal dilated circumference. However,
some protein changes may be dependent on the proximity
to the actual site of rupture. We cannot rule out that, with
this procedure, we have overlooked other proteins that also
could be important predictors for rupture.
Overall, it is important to notice that a number of
limitations apply to the present study. A relatively small
number of patients were analyzed. Furthermore, a limited
Fig 5. Western blotting analysis using anti-peroxiredo
non-ruptured AAA group (A) and 6 patient samples (1-
arrows are significantly differentially regulated in the
up-regulated and two vitronectin bands quantitated to
ruptured group (C).set of proteins are detected by the 2D-PAGE technique, ie,only proteins above a level of about 3 nanogram between pI
approximately 3 and 10 and molecular mass between about
10 and 200 kDa. A number of proteins found to be
differentially expressed in ruptured vs nonruptured AAA
tissue were not identified in the present study, a 4.9-fold
and a 19.5-fold up-regulated protein. The proteins are
probably of very low abundance and, therefore, difficult to
identify with the presently available technique.
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